Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AS101 for Chemotherapy Induced Thrombocytopenia
NCT00926354Phase 2Terminated
- Sponsor
- BioMAS Ltd
- Start
- Aug 2009
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of AS-101 in Thrombocytopenia (2 arms), sponsored by BioMAS Ltd. Primary endpoint: Incidence of thrombocytopenia events (platelets <70,000). Started Aug 2009; status: terminated.
02
Drugs
AS-101
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT00926354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00926354.